Evidence map›Paper›PMID 31705099›Full record

SynthesisBritish dental journal2019

Effects of krokodil (desomorphine) use on oral health - a systematic review.

Emma E J van Kempen, Henk S Brand

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in British dental journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Emma E J van KempenDepartment of Oral Biochemistry. Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands.
Henk S BrandDepartment of Oral Biochemistry. Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands. h.brand@acta.nl.
Academic Center for Dentistry Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction The narcotic drug krokodil is a semi-synthetic drug used as a cheap alternative to heroin. With its active ingredient desomorphine it is a highly addictive and destructive drug mainly used in Russia and Eastern Europe. Relatively little is known about the physical effects of krokodil. With this review we present more insight into oral health problems associated with krokodil use and how the use of this drug could influence dental and oral- and maxillofacial treatment.Methods The online electronic databases Pubmed, Web of Science, Cochrane Library and Google scholar were searched for articles concerning desomorphine or krokodil and oral side effects or pathology. Reference lists of included articles were manually screened for additional publications. Results Thirteen articles were included in this review. In total 684 patients were described in the included publications, mainly retrospective clinical case series and case reports. Eleven studies reported on osteonecrosis of the jaw and two studies reported on other physical and oral side effects associated with desomorphine abuse. Conclusion Osteonecrosis of the maxillofacial bones is a serious and mutilating oral side effect associated with krokodil use. Other oral aspects associated with its use include mucosal changes, high risk of caries and periodontitis. In addition, physical effects of the drug, which indirectly can affect oral health, have also been described. The use of the drug krokodil can interfere with dental and oral- and maxillofacial treatment.

Indexed as

Illicit DrugsOral HealthCodeineEurope, EasternHumansRetrospective StudiesCodeinedesomorphineIllicit Drugs

Identifiers

PMID31705099
OpenAlexW2987447802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.